CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 3 Insider Initial Statement of Ownership
- 8-K Event Other events
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Other events
- 8-K Event Material agreement
- 8-K Event Regulation FD disclosure
- 4 Open-market buy President and CEO bought 20,000 shares at $3.75 ($75,000)
- 4 Open-market buy Director bought 13,333 shares at $3.75 ($49,999)
- 4 Open-market buy Director bought 150,000 shares at $3.75 ($562,500)
- 4 Open-market buy Director bought 5,000,000 shares at $3.75 ($18,750,000)
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure · Other events
Page 41 of 62 · 1,224 filings